文献速递肝病消化道肿瘤与早癌

胆碱激酶α介导肝细胞癌细胞中表皮生长因子受体与雷帕霉素机制性靶点复合物2的相互作用以促进耐药和异种移植瘤进展

Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
PubMed 文献 · Gastroenterology · 2017-01-05

研究对9对肝细胞癌(HCC)及癌旁组织行全外显子组和转录组测序,并对120例原发HCC及癌旁组织行组织芯片分析。发现CHKA mRNA在HCC中常升高且与CHKA位点扩增相关,高表达者肿瘤更具侵袭性、术后生存更短;CHKA过表达增强HCC细胞迁移侵袭、形成更大且更多转移的异种移植瘤,并介导EGFR与mTORC2物理互作,该复合物为HCC细胞形成转移性异种移植瘤及对EGFR抑制剂耐药所必需。

要点

  • HCC组织中CHKA mRNA常升高,与CHKA位点扩增相关,高表达者术后生存更短。
  • CHKA过表达增强HCC细胞迁移侵袭,形成更大且更多转移的异种移植瘤。
  • CHKA介导EGFR与mTORC2互作,该复合物为HCC细胞转移及对EGFR抑制剂耐药所必需。

核心结论

  • 人HCC中CHKA水平较癌旁组织升高,高表达与肿瘤侵袭性及患者术后生存时间缩短相关。
  • HCC细胞系中过表达CHKA通过促进EGFR与mTORC2互作,增强侵袭性、对EGFR抑制剂耐药及形成转移性肿瘤的能力。

研究设计与样本

  • 对9对HCC及癌旁组织行全外显子组和转录组测序分析。
  • 对2006年1月至2009年12月在中国上海接受手术患者的120例原发HCC及癌旁组织行组织芯片分析,另分析48套HCC及癌旁标本。
  • 检测2株肝细胞系和7株HCC衍生细胞系的CHKA,并用小干扰RNA在3株HCC细胞系中敲低CHKA。
  • 行增殖、划痕愈合、迁移和侵袭实验,并将细胞经尾静脉注入小鼠以定量肿瘤生长和转移。
  • 行免疫沉淀和免疫荧光实验以确定CHKA与EGFR及mTORC2的相互作用。

主要发现

  • HCC组织中CHKA mRNA水平较癌旁组织常升高,升高与CHKA位点扩增相关。
  • 表达高水平CHKA的肿瘤侵袭性表型更强,患者术后生存时间较CHKA低表达者更短。
  • 稳定过表达CHKA的HCC细胞系迁移和侵袭水平高于对照HCC细胞,在小鼠中形成的异种移植瘤更大且转移更多。
  • CHKA为EGFR与mTORC2物理互作所必需,该复合物为HCC细胞在小鼠中形成转移性异种移植瘤及对EGFR抑制剂耐药所必需。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Choline kinase α (CHKA) catalyzes conversion of choline to phosphocholine and can contribute to carcinogenesis. Little is known about the role of CHKA in the pathogenesis of hepatocellular carcinoma (HCC). METHODS: We performed whole-exome and transcriptome sequence analyses of 9 paired HCC and non-tumor-adjacent tissues. We performed tissue chip analyses of 120 primary HCC and non-tumor-adjacent tissues from patients who received surgery in Shanghai, China from January 2006 through December 2009; 48 sets of specimens (HCC and non-tumor-adjacent tissues) were also analyzed. CHKA gene copy number was quantified and findings were validated by quantitative reverse transcription polymerase chain reaction analysis. CHKA messenger RNA and protein levels were determined by polymerase chain reaction, immunohistochemical, and immunoblot analyses. CHKA was examined in 2 hepatocyte cell lines and 7 HCC-derived cell lines, and knocked down with small interfering RNAs in 3 HCC cell lines. Cells were analyzed in proliferation, wound healing, migration, and invasion assays. Cells were injected into tail veins of mice and tumor growth and metastasis were quantified. Immunoprecipitation and immunofluorescence assays were conducted to determine interactions between CHKA and the epidermal growth factor receptor (EGFR) and the mechanistic target of rapamycin complex 2. RESULTS: Levels of CHKA messenger RNA were frequently increased in HCC tissues compared with nontumor tissues; increased expression was associated with amplification at the CHKA loci. Tumors that expressed high levels of CHKA had more aggressive phenotypes, and patients with these tumors had shorter survival times after surgery compared to patients whose tumors expressed low levels of CHKA. HCC cell lines that stably overexpressed CHKA had higher levels of migration and invasion than control HCC cells, and formed larger xenograft tumors with more metastases in mice compared to HCC cells that did not overexpress CHKA. CHKA was required for physical interaction between EGFR and mechanistic target of rapamycin complex 2. This complex was required for HCC cells to form metastatic xenograft tumors in mice and to become resistant to EGFR inhibitors. CONCLUSIONS: We found levels of CHKA to be increased in human HCCs compared to nontumor tissues, and increased expression to be associated with tumor aggressiveness and reduced survival times of patients. Overexpression of CHKA in HCC cell lines increased their invasiveness, resistance to EGFR inhibitors, and ability to form metastatic tumors in mice by promoting interaction of EGFR with mechanistic target of rapamycin complex 2.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Lin XM, Hu L, Gu J, et al. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Gastroenterology. 2017. PMID: 28065789. doi:10.1053/j.gastro.2016.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。